Press Release

NKS Health & Blue Charm Adherence Announce Strategic Collaboration

October 19, 2021
Return to all articles

NKS Health & Blue Charm Adherence Announce Strategic Collaboration on Digital Health Program for People Living With MS

Halifax, N.S. and Toronto, ON – October 19, 2021 – Blue Charm Adherence, a digital health solutions provider for the life sciences industry, is excited to announce a strategic collaboration with NKS Health, a leading specialty pharmacy serving all of Canada. NKS Health will launch the Blue Charm digital health platform across its national network of pharmacies to improve patient engagement and generate actionable insights through new sources of real-world data (RWD).

Through this partnership, NKS patients living with multiple sclerosis (MS) and prescribed a disease-modifying therapy (DMT) will have the opportunity to join Blue Charm's six-month Early Adopter Program. This program provides patients with access to the Blue Charm digital health platform and funding towards medication costs and eligible health-related expenses.

"We are thrilled to be working with NKS Health on bringing our digital health program to more patients across Canada," said Greg Patey, CEO, Blue Charm Adherence. "People living with MS face unique challenges throughout their care journey that we hope to help address with this program."

Don Swainson, Team Lead – National Programs, NKS Health & NKS Assist, added, "People with MS have a lot to deal with. The Blue Charm adherence tool should help patients who require a high-tech helper, to get the most from their medication. NKS is very pleased with this collaboration and look forward to learning from this pilot program."

About NKS HealthEstablished in 2007, NKS Health is a specialty pharmaceutical services company focused on the handling and service of injectable, infused, and biologic medications. NKS Health provides high-quality service by strategically focusing on chronic autoimmune and neurological conditions such as: rheumatoid arthritis, gastrointestinal diseases, dermatological diseases, stroke rehabilitation, migraines, and multiple sclerosis.

About Blue Charm AdherenceFounded in 2018, Blue Charm Adherence is a Canadian healthcare technology company. Blue Charm provides digital health infrastructure for life sciences companies, allowing them to deliver reward-based programs, collect real-world data (RWD) between appointments, and drive long-term patient engagement.

For further information about Blue Charm programs and services, including those in MS and other chronic diseases, please contact:

Dr. Greg Patey
CEO, Blue Charm Adherence
Email: g.patey@bluecharm.io

Articles you might like

Insights

Empowering Patients: The Crucial Role of Education in Respiratory Disease Management

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.
Insights

Five Insights from Blue Charm’s Respiratory Program in Partnership with the Canadian Lung Association

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients. 
Insights

The Next Frontier in Real-World Evidence: Unlocking the Patient Voice

The promise of Real-World Evidence/Data has always been to support clinical decision making with the highest possible quality of evidence. In practice, what does this actually mean and how does it enable us to provide better care for patients?